> top > docs > PubMed:21921061 > annotations

PubMed:21921061 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 5-8 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T2 5-8 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T3 9-13 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T4 9-13 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T5 85-88 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T6 85-88 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T7 89-93 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T8 89-93 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T9 326-329 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T10 326-329 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T11 330-334 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T12 330-334 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T13 634-637 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T14 634-637 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T15 638-641 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T16 638-641 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T17 646-650 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T18 646-650 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T19 651-655 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T20 651-655 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T21 759-762 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T22 759-762 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T23 763-767 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T24 763-767 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T25 1194-1197 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T26 1194-1197 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T27 1219-1223 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T28 1219-1223 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 5-8 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T3 9-13 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE
T5 85-88 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T7 89-93 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE
T9 326-329 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T11 330-334 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE
T13 634-637 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T15 638-641 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T17 646-650 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE
T19 651-655 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE
T21 759-762 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T23 763-767 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE
T25 1194-1197 Glycan_Motif denotes GM1 https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI
T27 1219-1223 Glycan_Motif denotes GD1a https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 5-8 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T2 5-8 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T3 9-13 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T4 9-13 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T5 85-88 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T6 85-88 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T7 89-93 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T8 89-93 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T9 326-329 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T10 326-329 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T11 330-334 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T12 330-334 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T13 634-637 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T14 634-637 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T15 638-641 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T16 638-641 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T17 646-650 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T18 646-650 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T19 651-655 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T20 651-655 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T21 759-762 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T22 759-762 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T23 763-767 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T24 763-767 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T25 1194-1197 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T26 1194-1197 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T27 1219-1223 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T28 1219-1223 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 0-8 http://www.glycoepitope.jp/epitopes/AN0713 denotes Anti-GM1
T2 5-8 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T3 9-13 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
T4 85-88 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T5 89-93 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
T6 326-329 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T7 330-334 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
T8 634-637 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T9 638-641 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T10 646-650 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
T11 651-655 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
T12 759-762 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T13 763-767 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
T14 1194-1197 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
T15 1219-1223 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a

ICD10

Id Subject Object Predicate Lexical cue
T1 174-197 http://purl.bioontology.org/ontology/ICD10/G61.0 denotes Guillain-Barré syndrome

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 22-32 FMAID:167180 denotes antibodies
_T2 139-149 FMAID:167180 denotes antibodies
_T3 259-271 FMAID:82816 denotes gangliosides
_T4 259-271 FMAID:196811 denotes gangliosides
_T5 275-286 FMAID:196811 denotes ganglioside
_T6 275-286 FMAID:82816 denotes ganglioside
_T7 342-353 FMAID:82816 denotes ganglioside
_T8 342-353 FMAID:196811 denotes ganglioside
_T9 406-421 FMAID:196731 denotes oligosaccharide
_T10 406-421 FMAID:82742 denotes oligosaccharide
_T11 459-467 FMAID:67745 denotes compound
_T12 459-467 FMAID:165656 denotes compound
_T13 656-665 FMAID:165656 denotes compounds
_T14 656-665 FMAID:67745 denotes compounds
_T15 726-738 FMAID:82816 denotes gangliosides
_T16 726-738 FMAID:196811 denotes gangliosides
_T17 848-863 FMAID:82742 denotes oligosaccharide
_T18 848-863 FMAID:196731 denotes oligosaccharide
_T19 864-874 FMAID:167180 denotes antibodies
_T20 904-920 FMAID:196731 denotes oligosaccharides
_T21 904-920 FMAID:82742 denotes oligosaccharides
_T22 977-987 FMAID:167180 denotes antibodies
_T23 1248-1263 FMAID:196731 denotes oligosaccharide
_T24 1248-1263 FMAID:82742 denotes oligosaccharide
_T25 1286-1297 FMAID:196811 denotes ganglioside
_T26 1286-1297 FMAID:82816 denotes ganglioside
_T27 1343-1351 FMAID:167180 denotes antibody
_T28 1423-1435 FMAID:196811 denotes gangliosides
_T29 1423-1435 FMAID:82816 denotes gangliosides

uniprot-human

Id Subject Object Predicate Lexical cue
T1 296-299 http://www.uniprot.org/uniprot/P56915 denotes GSC
T2 442-445 http://www.uniprot.org/uniprot/P56915 denotes GSC
T3 998-1001 http://www.uniprot.org/uniprot/P56915 denotes GSC

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 888-895 http://purl.bioontology.org/ontology/STY/T096 denotes grouped

GO-BP

Id Subject Object Predicate Lexical cue
T1 40-44 http://purl.obolibrary.org/obo/GO_0004617 denotes sera
T2 479-483 http://purl.obolibrary.org/obo/GO_0004617 denotes sera
T3 805-809 http://purl.obolibrary.org/obo/GO_0004617 denotes sera
T4 833-842 http://purl.obolibrary.org/obo/GO_0032502 denotes developed
T5 967-976 http://purl.obolibrary.org/obo/GO_0032502 denotes developed

GO-MF

Id Subject Object Predicate Lexical cue
T1 22-32 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T2 139-149 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T3 864-874 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T4 977-987 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T5 1343-1351 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody

GO-CC

Id Subject Object Predicate Lexical cue
T1 296-299 http://purl.obolibrary.org/obo/GO_0032593 denotes GSC
T2 442-445 http://purl.obolibrary.org/obo/GO_0032593 denotes GSC
T3 998-1001 http://purl.obolibrary.org/obo/GO_0032593 denotes GSC

Allie

Id Subject Object Predicate Lexical cue
SS1_21921061_1_0 174-197 expanded denotes Guillain-Barré syndrome
SS2_21921061_1_0 199-202 abbr denotes GBS
SS1_21921061_1_1 275-294 expanded denotes ganglioside complex
SS2_21921061_1_1 296-299 abbr denotes GSC
AE1_21921061_1_0 SS1_21921061_1_0 SS2_21921061_1_0 abbreviatedTo Guillain-Barré syndrome,GBS
AE1_21921061_1_1 SS1_21921061_1_1 SS2_21921061_1_1 abbreviatedTo ganglioside complex,GSC

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
TextSentencer_T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
TextSentencer_T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
TextSentencer_T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
TextSentencer_T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
TextSentencer_T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
TextSentencer_T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
TextSentencer_T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.
T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.
T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 5-8 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T2 85-88 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T3 326-329 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T4 634-637 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T5 638-641 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T6 759-762 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T7 1194-1197 http://www.glycoepitope.jp/epitopes/EP0050 denotes GM1
PD-GlycoEpitope-B_T8 0-8 http://www.glycoepitope.jp/epitopes/AN0713 denotes Anti-GM1
PD-GlycoEpitope-B_T9 9-13 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
PD-GlycoEpitope-B_T10 89-93 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
PD-GlycoEpitope-B_T11 330-334 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
PD-GlycoEpitope-B_T12 646-650 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
PD-GlycoEpitope-B_T13 651-655 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
PD-GlycoEpitope-B_T14 763-767 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a
PD-GlycoEpitope-B_T15 1219-1223 http://www.glycoepitope.jp/epitopes/EP0056 denotes GD1a

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 1184-1187 "http://rdf.glycoinfo.org/glycan/G93924TT" denotes Gal
GlycanIUPAC_T2 1209-1212 "http://rdf.glycoinfo.org/glycan/G93924TT" denotes Gal
GlycanIUPAC_T3 1184-1187 "http://rdf.glycoinfo.org/glycan/G25565DN" denotes Gal
GlycanIUPAC_T4 1209-1212 "http://rdf.glycoinfo.org/glycan/G25565DN" denotes Gal
GlycanIUPAC_T5 1184-1187 "http://rdf.glycoinfo.org/glycan/G97215EV" denotes Gal
GlycanIUPAC_T6 1209-1212 "http://rdf.glycoinfo.org/glycan/G97215EV" denotes Gal
GlycanIUPAC_T7 1184-1187 "http://rdf.glycoinfo.org/glycan/G79664KO" denotes Gal
GlycanIUPAC_T8 1209-1212 "http://rdf.glycoinfo.org/glycan/G79664KO" denotes Gal
GlycanIUPAC_T9 1184-1187 "http://rdf.glycoinfo.org/glycan/G24107FU" denotes Gal
GlycanIUPAC_T10 1209-1212 "http://rdf.glycoinfo.org/glycan/G24107FU" denotes Gal
GlycanIUPAC_T11 1184-1187 "http://rdf.glycoinfo.org/glycan/G09864UE" denotes Gal
GlycanIUPAC_T12 1209-1212 "http://rdf.glycoinfo.org/glycan/G09864UE" denotes Gal
GlycanIUPAC_T13 1184-1187 "http://rdf.glycoinfo.org/glycan/G28032MC" denotes Gal
GlycanIUPAC_T14 1209-1212 "http://rdf.glycoinfo.org/glycan/G28032MC" denotes Gal
GlycanIUPAC_T15 1184-1187 "http://rdf.glycoinfo.org/glycan/G28005UP" denotes Gal
GlycanIUPAC_T16 1209-1212 "http://rdf.glycoinfo.org/glycan/G28005UP" denotes Gal
GlycanIUPAC_T17 1184-1187 "http://rdf.glycoinfo.org/glycan/G92708AT" denotes Gal
GlycanIUPAC_T18 1209-1212 "http://rdf.glycoinfo.org/glycan/G92708AT" denotes Gal
GlycanIUPAC_T19 1184-1187 "http://rdf.glycoinfo.org/glycan/G73757UC" denotes Gal
GlycanIUPAC_T20 1209-1212 "http://rdf.glycoinfo.org/glycan/G73757UC" denotes Gal
GlycanIUPAC_T21 1184-1187 "http://rdf.glycoinfo.org/glycan/G51062DM" denotes Gal
GlycanIUPAC_T22 1209-1212 "http://rdf.glycoinfo.org/glycan/G51062DM" denotes Gal
GlycanIUPAC_T23 1184-1187 "http://rdf.glycoinfo.org/glycan/G05866BJ" denotes Gal
GlycanIUPAC_T24 1209-1212 "http://rdf.glycoinfo.org/glycan/G05866BJ" denotes Gal
GlycanIUPAC_T25 1184-1187 "http://rdf.glycoinfo.org/glycan/G87394FZ" denotes Gal
GlycanIUPAC_T26 1209-1212 "http://rdf.glycoinfo.org/glycan/G87394FZ" denotes Gal
GlycanIUPAC_T27 1184-1187 "http://rdf.glycoinfo.org/glycan/G03871NF" denotes Gal
GlycanIUPAC_T28 1209-1212 "http://rdf.glycoinfo.org/glycan/G03871NF" denotes Gal
GlycanIUPAC_T29 1184-1187 "http://rdf.glycoinfo.org/glycan/G29377VE" denotes Gal
GlycanIUPAC_T30 1209-1212 "http://rdf.glycoinfo.org/glycan/G29377VE" denotes Gal
GlycanIUPAC_T31 1184-1187 "http://rdf.glycoinfo.org/glycan/G33457CX" denotes Gal
GlycanIUPAC_T32 1209-1212 "http://rdf.glycoinfo.org/glycan/G33457CX" denotes Gal
GlycanIUPAC_T33 1184-1187 "http://rdf.glycoinfo.org/glycan/G97368GU" denotes Gal
GlycanIUPAC_T34 1209-1212 "http://rdf.glycoinfo.org/glycan/G97368GU" denotes Gal
GlycanIUPAC_T35 1184-1187 "http://rdf.glycoinfo.org/glycan/G18512EL" denotes Gal
GlycanIUPAC_T36 1209-1212 "http://rdf.glycoinfo.org/glycan/G18512EL" denotes Gal
GlycanIUPAC_T37 1184-1187 "http://rdf.glycoinfo.org/glycan/G41137VS" denotes Gal
GlycanIUPAC_T38 1209-1212 "http://rdf.glycoinfo.org/glycan/G41137VS" denotes Gal
GlycanIUPAC_T39 1184-1187 "http://rdf.glycoinfo.org/glycan/G30521NA" denotes Gal
GlycanIUPAC_T40 1209-1212 "http://rdf.glycoinfo.org/glycan/G30521NA" denotes Gal
GlycanIUPAC_T41 1184-1187 "http://rdf.glycoinfo.org/glycan/G19388CD" denotes Gal
GlycanIUPAC_T42 1209-1212 "http://rdf.glycoinfo.org/glycan/G19388CD" denotes Gal
GlycanIUPAC_T43 1184-1187 "http://rdf.glycoinfo.org/glycan/G53151FU" denotes Gal
GlycanIUPAC_T44 1209-1212 "http://rdf.glycoinfo.org/glycan/G53151FU" denotes Gal
GlycanIUPAC_T45 1184-1187 "http://rdf.glycoinfo.org/glycan/G27105XC" denotes Gal
GlycanIUPAC_T46 1209-1212 "http://rdf.glycoinfo.org/glycan/G27105XC" denotes Gal
GlycanIUPAC_T47 1184-1187 "http://rdf.glycoinfo.org/glycan/G91210VM" denotes Gal
GlycanIUPAC_T48 1209-1212 "http://rdf.glycoinfo.org/glycan/G91210VM" denotes Gal
GlycanIUPAC_T49 1184-1187 "http://rdf.glycoinfo.org/glycan/G40841DE" denotes Gal
GlycanIUPAC_T50 1209-1212 "http://rdf.glycoinfo.org/glycan/G40841DE" denotes Gal
GlycanIUPAC_T51 1184-1187 "http://rdf.glycoinfo.org/glycan/G71241HP" denotes Gal
GlycanIUPAC_T52 1209-1212 "http://rdf.glycoinfo.org/glycan/G71241HP" denotes Gal
GlycanIUPAC_T53 1184-1187 "http://rdf.glycoinfo.org/glycan/G84636BJ" denotes Gal
GlycanIUPAC_T54 1209-1212 "http://rdf.glycoinfo.org/glycan/G84636BJ" denotes Gal
GlycanIUPAC_T55 1184-1187 "http://rdf.glycoinfo.org/glycan/G47905LJ" denotes Gal
GlycanIUPAC_T56 1209-1212 "http://rdf.glycoinfo.org/glycan/G47905LJ" denotes Gal
GlycanIUPAC_T57 1184-1187 "http://rdf.glycoinfo.org/glycan/G39340DV" denotes Gal
GlycanIUPAC_T58 1209-1212 "http://rdf.glycoinfo.org/glycan/G39340DV" denotes Gal
GlycanIUPAC_T59 1184-1187 "http://rdf.glycoinfo.org/glycan/G48801AQ" denotes Gal
GlycanIUPAC_T60 1209-1212 "http://rdf.glycoinfo.org/glycan/G48801AQ" denotes Gal
GlycanIUPAC_T61 1184-1187 "http://rdf.glycoinfo.org/glycan/G14573NX" denotes Gal
GlycanIUPAC_T62 1209-1212 "http://rdf.glycoinfo.org/glycan/G14573NX" denotes Gal
GlycanIUPAC_T63 1184-1187 "http://rdf.glycoinfo.org/glycan/G56762TR" denotes Gal
GlycanIUPAC_T64 1209-1212 "http://rdf.glycoinfo.org/glycan/G56762TR" denotes Gal
GlycanIUPAC_T65 1184-1187 "http://rdf.glycoinfo.org/glycan/G20013XO" denotes Gal
GlycanIUPAC_T66 1209-1212 "http://rdf.glycoinfo.org/glycan/G20013XO" denotes Gal
GlycanIUPAC_T67 1184-1187 "http://rdf.glycoinfo.org/glycan/G39504DR" denotes Gal
GlycanIUPAC_T68 1209-1212 "http://rdf.glycoinfo.org/glycan/G39504DR" denotes Gal
GlycanIUPAC_T69 1184-1187 "http://rdf.glycoinfo.org/glycan/G35218RQ" denotes Gal
GlycanIUPAC_T70 1209-1212 "http://rdf.glycoinfo.org/glycan/G35218RQ" denotes Gal
GlycanIUPAC_T71 1184-1187 "http://rdf.glycoinfo.org/glycan/G53048SH" denotes Gal
GlycanIUPAC_T72 1209-1212 "http://rdf.glycoinfo.org/glycan/G53048SH" denotes Gal
GlycanIUPAC_T73 1184-1187 "http://rdf.glycoinfo.org/glycan/G78418IX" denotes Gal
GlycanIUPAC_T74 1209-1212 "http://rdf.glycoinfo.org/glycan/G78418IX" denotes Gal
GlycanIUPAC_T75 1184-1187 "http://rdf.glycoinfo.org/glycan/G09780OD" denotes Gal
GlycanIUPAC_T76 1209-1212 "http://rdf.glycoinfo.org/glycan/G09780OD" denotes Gal
GlycanIUPAC_T77 1184-1187 "http://rdf.glycoinfo.org/glycan/G56359GL" denotes Gal
GlycanIUPAC_T78 1209-1212 "http://rdf.glycoinfo.org/glycan/G56359GL" denotes Gal
GlycanIUPAC_T79 1184-1187 "http://rdf.glycoinfo.org/glycan/G78941YC" denotes Gal
GlycanIUPAC_T80 1209-1212 "http://rdf.glycoinfo.org/glycan/G78941YC" denotes Gal
GlycanIUPAC_T81 1184-1187 "http://rdf.glycoinfo.org/glycan/G26829FC" denotes Gal
GlycanIUPAC_T82 1209-1212 "http://rdf.glycoinfo.org/glycan/G26829FC" denotes Gal
GlycanIUPAC_T83 1184-1187 "http://rdf.glycoinfo.org/glycan/G88538ZC" denotes Gal
GlycanIUPAC_T84 1209-1212 "http://rdf.glycoinfo.org/glycan/G88538ZC" denotes Gal
GlycanIUPAC_T85 1184-1187 "http://rdf.glycoinfo.org/glycan/G46593ZR" denotes Gal
GlycanIUPAC_T86 1209-1212 "http://rdf.glycoinfo.org/glycan/G46593ZR" denotes Gal
GlycanIUPAC_T87 1184-1187 "http://rdf.glycoinfo.org/glycan/G43523TH" denotes Gal
GlycanIUPAC_T88 1209-1212 "http://rdf.glycoinfo.org/glycan/G43523TH" denotes Gal
GlycanIUPAC_T89 1184-1187 "http://rdf.glycoinfo.org/glycan/G36445ON" denotes Gal
GlycanIUPAC_T90 1209-1212 "http://rdf.glycoinfo.org/glycan/G36445ON" denotes Gal
GlycanIUPAC_T91 1184-1187 "http://rdf.glycoinfo.org/glycan/G67363FK" denotes Gal
GlycanIUPAC_T92 1209-1212 "http://rdf.glycoinfo.org/glycan/G67363FK" denotes Gal
GlycanIUPAC_T93 1184-1187 "http://rdf.glycoinfo.org/glycan/G17562KT" denotes Gal
GlycanIUPAC_T94 1209-1212 "http://rdf.glycoinfo.org/glycan/G17562KT" denotes Gal
GlycanIUPAC_T95 1184-1187 "http://rdf.glycoinfo.org/glycan/G24774YJ" denotes Gal
GlycanIUPAC_T96 1209-1212 "http://rdf.glycoinfo.org/glycan/G24774YJ" denotes Gal
GlycanIUPAC_T97 1184-1187 "http://rdf.glycoinfo.org/glycan/G32162UO" denotes Gal
GlycanIUPAC_T98 1209-1212 "http://rdf.glycoinfo.org/glycan/G32162UO" denotes Gal
GlycanIUPAC_T99 1184-1187 "http://rdf.glycoinfo.org/glycan/G89163RR" denotes Gal
GlycanIUPAC_T100 1209-1212 "http://rdf.glycoinfo.org/glycan/G89163RR" denotes Gal
GlycanIUPAC_T101 1184-1187 "http://rdf.glycoinfo.org/glycan/G99522DY" denotes Gal
GlycanIUPAC_T102 1209-1212 "http://rdf.glycoinfo.org/glycan/G99522DY" denotes Gal
GlycanIUPAC_T103 1184-1187 "http://rdf.glycoinfo.org/glycan/G59246IF" denotes Gal
GlycanIUPAC_T104 1209-1212 "http://rdf.glycoinfo.org/glycan/G59246IF" denotes Gal
GlycanIUPAC_T105 1184-1187 "http://rdf.glycoinfo.org/glycan/G95321NT" denotes Gal
GlycanIUPAC_T106 1209-1212 "http://rdf.glycoinfo.org/glycan/G95321NT" denotes Gal
GlycanIUPAC_T107 1184-1187 "http://rdf.glycoinfo.org/glycan/G17531ZI" denotes Gal
GlycanIUPAC_T108 1209-1212 "http://rdf.glycoinfo.org/glycan/G17531ZI" denotes Gal
GlycanIUPAC_T109 1184-1187 "http://rdf.glycoinfo.org/glycan/G54322SU" denotes Gal
GlycanIUPAC_T110 1209-1212 "http://rdf.glycoinfo.org/glycan/G54322SU" denotes Gal
GlycanIUPAC_T111 1184-1187 "http://rdf.glycoinfo.org/glycan/G72010DO" denotes Gal
GlycanIUPAC_T112 1209-1212 "http://rdf.glycoinfo.org/glycan/G72010DO" denotes Gal
GlycanIUPAC_T113 1184-1187 "http://rdf.glycoinfo.org/glycan/G44269EP" denotes Gal
GlycanIUPAC_T114 1209-1212 "http://rdf.glycoinfo.org/glycan/G44269EP" denotes Gal
GlycanIUPAC_T115 1184-1187 "http://rdf.glycoinfo.org/glycan/G57335AD" denotes Gal
GlycanIUPAC_T116 1209-1212 "http://rdf.glycoinfo.org/glycan/G57335AD" denotes Gal
GlycanIUPAC_T117 1184-1187 "http://rdf.glycoinfo.org/glycan/G60837LL" denotes Gal
GlycanIUPAC_T118 1209-1212 "http://rdf.glycoinfo.org/glycan/G60837LL" denotes Gal
GlycanIUPAC_T119 1184-1187 "http://rdf.glycoinfo.org/glycan/G61929XX" denotes Gal
GlycanIUPAC_T120 1209-1212 "http://rdf.glycoinfo.org/glycan/G61929XX" denotes Gal
GlycanIUPAC_T121 1184-1187 "http://rdf.glycoinfo.org/glycan/G88747RA" denotes Gal
GlycanIUPAC_T122 1209-1212 "http://rdf.glycoinfo.org/glycan/G88747RA" denotes Gal
GlycanIUPAC_T123 1184-1187 "http://rdf.glycoinfo.org/glycan/G47955HA" denotes Gal
GlycanIUPAC_T124 1209-1212 "http://rdf.glycoinfo.org/glycan/G47955HA" denotes Gal
GlycanIUPAC_T125 1184-1187 "http://rdf.glycoinfo.org/glycan/G60982WS" denotes Gal
GlycanIUPAC_T126 1209-1212 "http://rdf.glycoinfo.org/glycan/G60982WS" denotes Gal
GlycanIUPAC_T127 1184-1187 "http://rdf.glycoinfo.org/glycan/G37035KG" denotes Gal
GlycanIUPAC_T128 1209-1212 "http://rdf.glycoinfo.org/glycan/G37035KG" denotes Gal
GlycanIUPAC_T129 1184-1187 "http://rdf.glycoinfo.org/glycan/G46297FI" denotes Gal
GlycanIUPAC_T130 1209-1212 "http://rdf.glycoinfo.org/glycan/G46297FI" denotes Gal
GlycanIUPAC_T131 1184-1187 "http://rdf.glycoinfo.org/glycan/G35475KI" denotes Gal
GlycanIUPAC_T132 1209-1212 "http://rdf.glycoinfo.org/glycan/G35475KI" denotes Gal
GlycanIUPAC_T133 1184-1187 "http://rdf.glycoinfo.org/glycan/G29771JN" denotes Gal
GlycanIUPAC_T134 1209-1212 "http://rdf.glycoinfo.org/glycan/G29771JN" denotes Gal
GlycanIUPAC_T135 1184-1187 "http://rdf.glycoinfo.org/glycan/G61285YR" denotes Gal
GlycanIUPAC_T136 1209-1212 "http://rdf.glycoinfo.org/glycan/G61285YR" denotes Gal
GlycanIUPAC_T137 1184-1187 "http://rdf.glycoinfo.org/glycan/G54785MW" denotes Gal
GlycanIUPAC_T138 1209-1212 "http://rdf.glycoinfo.org/glycan/G54785MW" denotes Gal
GlycanIUPAC_T139 1184-1187 "http://rdf.glycoinfo.org/glycan/G53039GT" denotes Gal
GlycanIUPAC_T140 1209-1212 "http://rdf.glycoinfo.org/glycan/G53039GT" denotes Gal
GlycanIUPAC_T141 1184-1187 "http://rdf.glycoinfo.org/glycan/G00601HK" denotes Gal
GlycanIUPAC_T142 1209-1212 "http://rdf.glycoinfo.org/glycan/G00601HK" denotes Gal
GlycanIUPAC_T143 1184-1187 "http://rdf.glycoinfo.org/glycan/G10485IJ" denotes Gal
GlycanIUPAC_T144 1209-1212 "http://rdf.glycoinfo.org/glycan/G10485IJ" denotes Gal
GlycanIUPAC_T145 1184-1187 "http://rdf.glycoinfo.org/glycan/G16393IB" denotes Gal
GlycanIUPAC_T146 1209-1212 "http://rdf.glycoinfo.org/glycan/G16393IB" denotes Gal
GlycanIUPAC_T147 1184-1187 "http://rdf.glycoinfo.org/glycan/G98436FZ" denotes Gal
GlycanIUPAC_T148 1209-1212 "http://rdf.glycoinfo.org/glycan/G98436FZ" denotes Gal
GlycanIUPAC_T149 1184-1187 "http://rdf.glycoinfo.org/glycan/G18825IA" denotes Gal
GlycanIUPAC_T150 1209-1212 "http://rdf.glycoinfo.org/glycan/G18825IA" denotes Gal
GlycanIUPAC_T151 1184-1187 "http://rdf.glycoinfo.org/glycan/G61281HQ" denotes Gal
GlycanIUPAC_T152 1209-1212 "http://rdf.glycoinfo.org/glycan/G61281HQ" denotes Gal
GlycanIUPAC_T153 1184-1187 "http://rdf.glycoinfo.org/glycan/G07798TI" denotes Gal
GlycanIUPAC_T154 1209-1212 "http://rdf.glycoinfo.org/glycan/G07798TI" denotes Gal
GlycanIUPAC_T155 1184-1187 "http://rdf.glycoinfo.org/glycan/G55921QA" denotes Gal
GlycanIUPAC_T156 1209-1212 "http://rdf.glycoinfo.org/glycan/G55921QA" denotes Gal
GlycanIUPAC_T157 1184-1187 "http://rdf.glycoinfo.org/glycan/G99066DL" denotes Gal
GlycanIUPAC_T158 1209-1212 "http://rdf.glycoinfo.org/glycan/G99066DL" denotes Gal
GlycanIUPAC_T159 1184-1187 "http://rdf.glycoinfo.org/glycan/G33451PQ" denotes Gal
GlycanIUPAC_T160 1209-1212 "http://rdf.glycoinfo.org/glycan/G33451PQ" denotes Gal
GlycanIUPAC_T161 1184-1187 "http://rdf.glycoinfo.org/glycan/G02111XU" denotes Gal
GlycanIUPAC_T162 1209-1212 "http://rdf.glycoinfo.org/glycan/G02111XU" denotes Gal
GlycanIUPAC_T163 1184-1187 "http://rdf.glycoinfo.org/glycan/G85193OM" denotes Gal
GlycanIUPAC_T164 1209-1212 "http://rdf.glycoinfo.org/glycan/G85193OM" denotes Gal
GlycanIUPAC_T165 1184-1187 "http://rdf.glycoinfo.org/glycan/G89174YQ" denotes Gal
GlycanIUPAC_T166 1209-1212 "http://rdf.glycoinfo.org/glycan/G89174YQ" denotes Gal
GlycanIUPAC_T167 1184-1187 "http://rdf.glycoinfo.org/glycan/G28802LE" denotes Gal
GlycanIUPAC_T168 1209-1212 "http://rdf.glycoinfo.org/glycan/G28802LE" denotes Gal
GlycanIUPAC_T169 1184-1187 "http://rdf.glycoinfo.org/glycan/G56061JK" denotes Gal
GlycanIUPAC_T170 1209-1212 "http://rdf.glycoinfo.org/glycan/G56061JK" denotes Gal
GlycanIUPAC_T171 1184-1187 "http://rdf.glycoinfo.org/glycan/G68941BC" denotes Gal
GlycanIUPAC_T172 1209-1212 "http://rdf.glycoinfo.org/glycan/G68941BC" denotes Gal
GlycanIUPAC_T173 1184-1187 "http://rdf.glycoinfo.org/glycan/G55436FC" denotes Gal
GlycanIUPAC_T174 1209-1212 "http://rdf.glycoinfo.org/glycan/G55436FC" denotes Gal
GlycanIUPAC_T175 1184-1187 "http://rdf.glycoinfo.org/glycan/G24002PU" denotes Gal
GlycanIUPAC_T176 1209-1212 "http://rdf.glycoinfo.org/glycan/G24002PU" denotes Gal
GlycanIUPAC_T177 1184-1187 "http://rdf.glycoinfo.org/glycan/G61387SV" denotes Gal
GlycanIUPAC_T178 1209-1212 "http://rdf.glycoinfo.org/glycan/G61387SV" denotes Gal
GlycanIUPAC_T179 1184-1187 "http://rdf.glycoinfo.org/glycan/G31834HW" denotes Gal
GlycanIUPAC_T180 1209-1212 "http://rdf.glycoinfo.org/glycan/G31834HW" denotes Gal
GlycanIUPAC_T181 1184-1187 "http://rdf.glycoinfo.org/glycan/G35324RT" denotes Gal
GlycanIUPAC_T182 1209-1212 "http://rdf.glycoinfo.org/glycan/G35324RT" denotes Gal
GlycanIUPAC_T183 1184-1187 "http://rdf.glycoinfo.org/glycan/G34803QO" denotes Gal
GlycanIUPAC_T184 1209-1212 "http://rdf.glycoinfo.org/glycan/G34803QO" denotes Gal
GlycanIUPAC_T185 1184-1187 "http://rdf.glycoinfo.org/glycan/G92898FF" denotes Gal
GlycanIUPAC_T186 1209-1212 "http://rdf.glycoinfo.org/glycan/G92898FF" denotes Gal
GlycanIUPAC_T187 1184-1187 "http://rdf.glycoinfo.org/glycan/G01318VX" denotes Gal
GlycanIUPAC_T188 1209-1212 "http://rdf.glycoinfo.org/glycan/G01318VX" denotes Gal
GlycanIUPAC_T189 1184-1187 "http://rdf.glycoinfo.org/glycan/G83200MX" denotes Gal
GlycanIUPAC_T190 1209-1212 "http://rdf.glycoinfo.org/glycan/G83200MX" denotes Gal
GlycanIUPAC_T191 1184-1187 "http://rdf.glycoinfo.org/glycan/G56286UC" denotes Gal
GlycanIUPAC_T192 1209-1212 "http://rdf.glycoinfo.org/glycan/G56286UC" denotes Gal
GlycanIUPAC_T193 1184-1187 "http://rdf.glycoinfo.org/glycan/G07304QA" denotes Gal
GlycanIUPAC_T194 1209-1212 "http://rdf.glycoinfo.org/glycan/G07304QA" denotes Gal
GlycanIUPAC_T195 1184-1187 "http://rdf.glycoinfo.org/glycan/G06868OU" denotes Gal
GlycanIUPAC_T196 1209-1212 "http://rdf.glycoinfo.org/glycan/G06868OU" denotes Gal
GlycanIUPAC_T197 1184-1187 "http://rdf.glycoinfo.org/glycan/G12647BS" denotes Gal
GlycanIUPAC_T198 1209-1212 "http://rdf.glycoinfo.org/glycan/G12647BS" denotes Gal
GlycanIUPAC_T199 1184-1187 "http://rdf.glycoinfo.org/glycan/G51841DF" denotes Gal
GlycanIUPAC_T200 1209-1212 "http://rdf.glycoinfo.org/glycan/G51841DF" denotes Gal
GlycanIUPAC_T201 1184-1187 "http://rdf.glycoinfo.org/glycan/G32122AJ" denotes Gal
GlycanIUPAC_T202 1209-1212 "http://rdf.glycoinfo.org/glycan/G32122AJ" denotes Gal
GlycanIUPAC_T203 1184-1187 "http://rdf.glycoinfo.org/glycan/G41125MN" denotes Gal
GlycanIUPAC_T204 1209-1212 "http://rdf.glycoinfo.org/glycan/G41125MN" denotes Gal
GlycanIUPAC_T205 1184-1187 "http://rdf.glycoinfo.org/glycan/G16093XS" denotes Gal
GlycanIUPAC_T206 1209-1212 "http://rdf.glycoinfo.org/glycan/G16093XS" denotes Gal
GlycanIUPAC_T207 1184-1187 "http://rdf.glycoinfo.org/glycan/G62425IX" denotes Gal
GlycanIUPAC_T208 1209-1212 "http://rdf.glycoinfo.org/glycan/G62425IX" denotes Gal
GlycanIUPAC_T209 1184-1187 "http://rdf.glycoinfo.org/glycan/G15673TO" denotes Gal
GlycanIUPAC_T210 1209-1212 "http://rdf.glycoinfo.org/glycan/G15673TO" denotes Gal
GlycanIUPAC_T211 1184-1187 "http://rdf.glycoinfo.org/glycan/G32857IK" denotes Gal
GlycanIUPAC_T212 1209-1212 "http://rdf.glycoinfo.org/glycan/G32857IK" denotes Gal
GlycanIUPAC_T213 1184-1187 "http://rdf.glycoinfo.org/glycan/G60047CJ" denotes Gal
GlycanIUPAC_T214 1209-1212 "http://rdf.glycoinfo.org/glycan/G60047CJ" denotes Gal
GlycanIUPAC_T215 1184-1187 "http://rdf.glycoinfo.org/glycan/G55718ZB" denotes Gal
GlycanIUPAC_T216 1209-1212 "http://rdf.glycoinfo.org/glycan/G55718ZB" denotes Gal
GlycanIUPAC_T217 1184-1187 "http://rdf.glycoinfo.org/glycan/G88355ZE" denotes Gal
GlycanIUPAC_T218 1209-1212 "http://rdf.glycoinfo.org/glycan/G88355ZE" denotes Gal
GlycanIUPAC_T219 1184-1187 "http://rdf.glycoinfo.org/glycan/G11283PA" denotes Gal
GlycanIUPAC_T220 1209-1212 "http://rdf.glycoinfo.org/glycan/G11283PA" denotes Gal
GlycanIUPAC_T221 1184-1187 "http://rdf.glycoinfo.org/glycan/G71737IZ" denotes Gal
GlycanIUPAC_T222 1209-1212 "http://rdf.glycoinfo.org/glycan/G71737IZ" denotes Gal
GlycanIUPAC_T223 1184-1187 "http://rdf.glycoinfo.org/glycan/G60912WZ" denotes Gal
GlycanIUPAC_T224 1209-1212 "http://rdf.glycoinfo.org/glycan/G60912WZ" denotes Gal
GlycanIUPAC_T225 1184-1187 "http://rdf.glycoinfo.org/glycan/G99655SO" denotes Gal
GlycanIUPAC_T226 1209-1212 "http://rdf.glycoinfo.org/glycan/G99655SO" denotes Gal
GlycanIUPAC_T227 1184-1187 "http://rdf.glycoinfo.org/glycan/G10300TW" denotes Gal
GlycanIUPAC_T228 1209-1212 "http://rdf.glycoinfo.org/glycan/G10300TW" denotes Gal
GlycanIUPAC_T229 1184-1187 "http://rdf.glycoinfo.org/glycan/G89509FL" denotes Gal
GlycanIUPAC_T230 1209-1212 "http://rdf.glycoinfo.org/glycan/G89509FL" denotes Gal
GlycanIUPAC_T231 1184-1187 "http://rdf.glycoinfo.org/glycan/G31465TH" denotes Gal
GlycanIUPAC_T232 1209-1212 "http://rdf.glycoinfo.org/glycan/G31465TH" denotes Gal
GlycanIUPAC_T233 1184-1187 "http://rdf.glycoinfo.org/glycan/G94101LU" denotes Gal
GlycanIUPAC_T234 1209-1212 "http://rdf.glycoinfo.org/glycan/G94101LU" denotes Gal
GlycanIUPAC_T235 1184-1187 "http://rdf.glycoinfo.org/glycan/G38610BB" denotes Gal
GlycanIUPAC_T236 1209-1212 "http://rdf.glycoinfo.org/glycan/G38610BB" denotes Gal
GlycanIUPAC_T237 1184-1187 "http://rdf.glycoinfo.org/glycan/G85893UF" denotes Gal
GlycanIUPAC_T238 1209-1212 "http://rdf.glycoinfo.org/glycan/G85893UF" denotes Gal

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 36-39 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T2 174-197 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T3 199-202 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T4 489-492 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T5 815-818 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T6 954-957 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 5-8 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T2 9-13 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T3 85-88 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T4 89-93 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T5 326-329 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T6 330-334 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T7 634-637 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T8 638-641 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T9 646-650 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T10 651-655 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T11 759-762 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T12 763-767 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T13 1194-1197 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T14 1219-1223 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 0-8 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T2 9-13 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T3 85-88 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T4 89-93 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T5 326-329 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T6 330-334 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T7 634-637 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T8 638-641 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T9 646-650 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T10 651-655 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T11 759-762 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T12 763-767 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T13 1194-1197 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T14 1219-1223 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 36-39 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T2 174-197 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T3 199-202 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T4 489-492 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T5 815-818 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T6 954-957 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 799-804 OrganismTaxon denotes human 9606

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 527-532 Body_part denotes layer http://purl.obolibrary.org/obo/UBERON_0000119|http://purl.obolibrary.org/obo/UBERON_0022303

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
TextSentencer_T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
TextSentencer_T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
TextSentencer_T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
TextSentencer_T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
TextSentencer_T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
TextSentencer_T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
TextSentencer_T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.
T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.
T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-94 Sentence denotes Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
T2 95-301 Sentence denotes It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC).
T3 302-446 Sentence denotes We prepared the dimeric GM1-GD1a hybrid ganglioside derivative that contains two structurally different oligosaccharide chains to mimic the GSC.
T4 447-601 Sentence denotes We use this compound to analyze sera from GBS patients by high-performance thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay.
T5 602-739 Sentence denotes We also synthesized the dimeric GM1-GM1 and GD1a-GD1a compounds that were used in control experiments together with natural gangliosides.
T6 740-1002 Sentence denotes The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC.
T7 1003-1359 Sentence denotes High-resolution (1)H-(13)C heteronuclear single-quantum coherence-nuclear overhauser effect spectroscopy nuclear magnetic resonance experiments showed an interaction between the IV Gal-H1 of GM1 and the IV Gal-H2 of GD1a suggesting that the two oligosaccharide chains of the dimeric ganglioside form a single epitope recognized by a single-antibody domain.
T8 1360-1576 Sentence denotes The availability of a method capable to prepare several hybrid gangliosides, and the availability of simple analytical approaches, opens new perspectives for the understanding and the therapy of several neuropathies.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 5-8 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T2 9-13 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T3 85-88 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T4 89-93 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T5 326-329 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T6 330-334 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T7 634-637 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T8 638-641 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T9 646-650 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T10 651-655 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T11 759-762 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T12 763-767 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE
T13 1194-1197 Glycan denotes GM1 https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR
T14 1219-1223 Glycan denotes GD1a https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 0-8 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T2 9-13 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T3 85-88 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T4 89-93 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T5 326-329 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T6 330-334 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T7 634-637 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T8 638-641 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T9 646-650 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T10 651-655 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T11 759-762 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T12 763-767 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T13 1194-1197 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T14 1219-1223 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 799-804 OrganismTaxon denotes human 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 527-532 Body_part denotes layer http://purl.obolibrary.org/obo/UBERON_0000119|http://purl.obolibrary.org/obo/UBERON_0022303